INSY - INSYS Therapeutics, Inc.

NasdaqGM - NasdaqGM Delayed Price. Currency in USD
7.79
-0.31 (-3.83%)
At close: 4:00PM EST
Stock chart is not supported by your current browser
Previous Close8.10
Open8.28
Bid7.75 x 5000
Ask7.93 x 200
Day's Range7.76 - 8.28
52 Week Range4.10 - 15.02
Volume636,945
Avg. Volume1,672,755
Market Cap571.136M
Beta2.19
PE Ratio (TTM)N/A
EPS (TTM)-2.57
Earnings DateApr 2, 2018 - Apr 6, 2018
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est9.80
Trade prices are not sourced from all markets
  • TheStreet.com7 days ago

    Opioid Litigants Get Boost From Senate Report

    A report released by Missouri Sen. Claire McCaskill points to $10 million of payments flowing from a group of five opioid-producing companies to 15 patient advocacy groups over a five-year period.

  • Reuters7 days ago

    Opioid makers paid millions to advocacy groups -U.S. Senate report

    Five opioid manufacturers including OxyContin maker Purdue Pharma LP have paid more than $10 million to advocacy groups and doctors tied to them, many of whom amplified industry messages supporting the use of the painkillers, a U.S. Senate report said on Monday. The report, released by Democratic Senator Claire McCaskill, said groups who received the donations aligned themselves with industry goals and may have played a role in an epidemic that in 2016 led to 42,000 opioid overdose deaths. The report released by McCaskill, the U.S. Senate Homeland Security and Governmental Affairs Committee's ranking Democrat, said the groups issued guidance promoting opioids for chronic pain and lobbied against laws to curb their use.

  • Stocks give up early gains, Trump signs budget bill
    Yahoo Finance11 days ago

    Stocks give up early gains, Trump signs budget bill

    Yahoo Finance's LIVE market coverage and analysis of stocks and bonds begins each day at 11:45 a.m. ET.

  • GlobeNewswire11 days ago

    INSYS Therapeutics Addresses Maryland Attorney General’s Motion

    PHOENIX, Feb. 09, 2018-- INSYS Therapeutics, Inc., a leader in the development, manufacture and commercialization of pharmaceutical cannabinoids and spray technology, today released the following statement ...

  • Reuters12 days ago

    Maryland sues Insys to enforce subpoena in opioid probe

    Maryland's attorney general has filed a lawsuit seeking to enforce a subpoena the state sent Insys Therapeutics Inc as part of a probe into allegations the drugmaker deceptively marketed a fentanyl-based cancer pain medicine. Maryland Attorney General Brian Frosh confirmed on Thursday that his office filed a lawsuit in state court after Insys resisted turning over documents sought as part of an investigation into the drugmaker's role in the opioid epidemic. Frosh said the state had been investigating the Chandler, Arizona-based company since 2016 amid allegations that Insys had marketed its product Subsys to not just patients with severe cancer pain but for other conditions.

  • American City Business Journals15 days ago

    See which Valley public companies were among U.S. stocks that suffered the most last week

    The U.S. stock markets had their worst week in months last week, ending with the biggest loss since President Donald Trump took office on Friday. The plunge came after U.S. jobs figures were announced ...

  • Look Beyond Pharma to Invest in Marijuana Industry
    Insider Monkey18 days ago

    Look Beyond Pharma to Invest in Marijuana Industry

    In this article we are going to present an alternative to weed stocks such as GW Pharmaceuticals PLC- ADR (NASDAQ:GWPH), Cara Therapeutics Inc (NASDAQ:CARA), Zynerba Pharmaceuticals Inc (NASDAQ:ZYNE), Corbus Pharmaceuticals Holdings Inc (NASDAQ:CRBP), and Insys Therapeutics Inc (NASDAQ:INSY). When it comes to investing in the marijuana industry many people think about stocks of companies that are either growing and/or selling […]

  • Reuters18 days ago

    New York accuses Insys of deceptively marketing opioid

    Insys Therapeutics Inc's legal woes deepened on Thursday as New York's attorney general filed a lawsuit seeking at least $75 million from the company, which he said deceptively promoted a fentanyl-based cancer pain medicine for unsafe uses. New York Attorney General Eric Schneiderman alleged that the Chandler, Arizona-based drugmaker recklessly marketed its product Subsys for wider uses than the U.S. Food and Drug Administration approved and bribed doctors to prescribe it. "At a time when the opioid epidemic was ravaging New York, Insys Therapeutics allegedly marketed a drug illegally by blatantly disregarding the grave risks of addiction and death that opioids pose," Schneiderman said in a statement.

  • GlobeNewswire18 days ago

    INSYS Therapeutics Addresses New York Attorney General’s Complaint

    PHOENIX, Feb. 01, 2018-- INSYS Therapeutics, Inc., a leader in the development, manufacture and commercialization of pharmaceutical cannabinoids and spray technology, today released the following statement ...

  • Investopedia19 days ago

    Top 4 Marijuana Stocks to Watch

    These four stocks are top picks that capitalize on the marijuana industry.

  • GlobeNewswire19 days ago

    INSYS Therapeutics Appoints Vaseem Mahboob to Board of Directors

    PHOENIX, Feb. 01, 2018-- INSYS Therapeutics, Inc., a leader in the development, manufacture and commercialization of pharmaceutical cannabinoids and spray technology, today announced the appointment of ...

  • GlobeNewswire21 days ago

    INSYS Therapeutics Adds Two New Executives to Senior Management Team

    VP of Human Resources, Carol Summersgill; VP of Clinical Development, Dr. PHOENIX, Jan. 30, 2018-- INSYS Therapeutics, Inc., a leader in the development, manufacture and commercialization of pharmaceutical ...

  • Why Marijuana and Cryptocurrency Investments Differ
    Market Realist22 days ago

    Why Marijuana and Cryptocurrency Investments Differ

    In the earlier part of this series, we briefly discussed why investors have recently rushed into cryptocurrencies and marijuana. In this part, we’ll discuss the difference between these investment opportunities, starting with the marijuana industry (MJX). Businesses exist to provide value to an end user, and marijuana’s end use has been fairly well-established. There has been an established market for medical marijuana in several countries.

  • Benzinga27 days ago

    Cannabis Industry Group Announces National Standards, Starts With Marijuana Product Packaging And Labeling

    One of the consequences of cannabis remaining federally illegal is the lack of unified standards for operating businesses. Every state, municipality and jurisdiction compels marijuana businesses to fulfill ...

  • What Vermont Can Learn from Washington’s Marijuana Tax
    Market Realist28 days ago

    What Vermont Can Learn from Washington’s Marijuana Tax

    In the previous article in this series, we saw that Vermont decriminalized recreational marijuana on January 22, 2018. With no legality covering the sale of marijuana and no tax revenues from these sales, what would motivate Vermont to legalize recreational marijuana?

  • Vermont Legalizes Recreational Marijuana on January 22, 2018
    Market Realist28 days ago

    Vermont Legalizes Recreational Marijuana on January 22, 2018

    On January 22, 2018, Vermont decriminalized the possession of marijuana for adults 21 and older. With increasing attention on the legalization of recreational marijuana in recent months, Vermont became the ninth state in the US to legalize marijuana for recreational purposes. This move comes almost six years after recreational marijuana became legal in Colorado and Washington.

  • The Other Side of Legalizing Recreational Marijuana
    Market Realist28 days ago

    The Other Side of Legalizing Recreational Marijuana

    While marijuana legalization for recreational use is just gaining attention around the world, it’s also facing strong opposition. According to some, legalizing marijuana will just increase substance abuse. Some groups are concerned that legalizing marijuana would make it even easier for young people to access the drug.

  • What a Country Could Gain from Legalizing Recreational Marijuana
    Market Realist28 days ago

    What a Country Could Gain from Legalizing Recreational Marijuana

    In the previous part of this series, we saw how the legalization of recreational marijuana could create related business opportunities. In this part, we’ll discuss the potential upside of recreational marijuana for a country like Canada. According to Deloitte, recreational marijuana alone could be a $5 billion industry initially, and it could go as high as $8.7 billion.

  • The Marijuana Ecosystem’s Potential Business Opportunities
    Market Realist28 days ago

    The Marijuana Ecosystem’s Potential Business Opportunities

    In the previous part of this series, we discussed Constellation Brands’ (STZ) investment in the marijuana industry. Given that legislative approval is the strongest driving factor behind the boost in the marijuana industry, companies have rushed to capitalize on the wave. Below, we discuss some of the business opportunities that could develop as a result of marijuana legalization.

  • Is Investment in the Marijuana Space Picking Up?
    Market Realist29 days ago

    Is Investment in the Marijuana Space Picking Up?

    In the previous part of this series, we saw that the alcohol industry could expect marijuana legalization for recreational purposes as an extension to their growth strategy. With too much confusion surrounding the legalities of the marijuana industry, some seasoned players appear highly optimistic about the future of recreational marijuana. Late last year, Constellation Brands (STZ) agreed to acquire a 9.9% stake in the Canada-based Canopy Growth for about $191.3 million.

  • The Motivation for Recreational Marijuana Consumption
    Market Realist29 days ago

    The Motivation for Recreational Marijuana Consumption

    In this part, we look at the secondary use of marijuana, recreational use. In mid-2018, Canada is expected to make marijuana legal for recreational use. This outlook has been driving stocks such as Aurora Cannabis (ACB.TO), Canopy Growth (WEED.TO), Aphria (APH.TO), and MedReleaf (LEAF.TO) to new highs.

  • Why the Medical Marijuana Industry Is Growing
    Market Realist29 days ago

    Why the Medical Marijuana Industry Is Growing

    Must-Knows before Investing in the Marijuana Industry

  • How Marijuana Acceptance Is Evolving Globally
    Market Realistlast month

    How Marijuana Acceptance Is Evolving Globally

    It’s fascinating to see how the marijuana landscape around the world has evolved in the last three years. According to Canopy Growth (WEED.TO), Canada, Israel, the Czech Republic, Uruguay, and the Netherlands “established federally legal cannabis access regimes” in 2014. Globally, the acceptance of marijuana evolved further in 2017 with more countries either legalizing cannabis access at a federal level or exploring the possibility of legalizing cannabis.

  • Must-Knows before Investing in the Marijuana Industry
    Market Realistlast month

    Must-Knows before Investing in the Marijuana Industry

    Must-Knows before Investing in the Marijuana IndustryInvesting in marijuana

  • Benzingalast month

    Colorado Cannabis Sales Hit $1.49 Billion In 2017: Taxes Up To $247 Million, Medical Sales Down To $420 Million

    The state of Colorado has released its 2017 legal cannabis tax data, reporting collections of $247.36 million, up from $193.6 million in 2016. Based on these figures, financial analysis and research firm ...